Clinical Intelligence Report — 2026-03-01

March 1, 2026

Clinical Intelligence Report

Window: Last 30 days
Study posts included: 240

Top Conditions

Unknown — 240

Study Types

Unknown — 240

Modalities

Unknown — 240

Biomarkers (Top 20)

Outcomes (Top 20)

Effect Direction

Unknown — 240

Add an API key in Settings → MyNeuroNews Insights to enable the narrative brief.

Leave a Comment Cancel Reply

Clinical Intelligence Report — 2026-03-01
Clinical Intelligence Report Window: Last 30 daysStudy posts included: 240 Top Conditions Unknown — 240 Study Types Unknown — 240 Modalities Unknown — 240 Biomarkers (Top 20) Outcomes (Top 20) Effect Direction Unknown — 240 Add an API key in Settings → MyNeuroNews Insights to enable the narrative brief.
Contribution of sclerotherapy to the management of chronic venous insufficiency at the Abidjan Heart Institute: A preliminary study
Study Overview This preliminary study examines the effects of sclerotherapy in managing chronic venous insufficiency (CVI) at the Abidjan Heart Institute. Chronic venous insufficiency is a condition where the veins struggle to send blood from the limbs back to the heart, leading to symptoms such as swelling, pain, and skin changes. This condition significantly impacts… Read more: Contribution of sclerotherapy to the management of chronic venous insufficiency at the Abidjan Heart Institute: A preliminary study
ACR Appropriateness Criteria Demyelinating Diseases
Understanding Demyelinating Diseases Demyelinating diseases represent a group of neurological disorders characterized by the loss or damage of the myelin sheath, the protective covering that surrounds nerve fibers within the central nervous system (CNS). Myelin plays a crucial role in facilitating the rapid transmission of electrical impulses along nerve cells, and its degradation leads to… Read more: ACR Appropriateness Criteria Demyelinating Diseases
Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission
Real-World Applications Rituximab has emerged as a significant therapeutic agent in the field of neuroimmunology, particularly for conditions such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). While clinical trials have shown its efficacy, real-world applications provide a deeper understanding of its effectiveness in diverse patient populations and settings. In clinical practice, rituximab… Read more: Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission
The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study
Study Overview Recent research has begun to shed light on the C-Reactive Protein-Triglyceride Glucose (CRP-TG) index as a potential biomarker for predicting the onset of chronic diseases. This study was conducted using a longitudinal cohort design, which enables researchers to observe changes over time within the same population. This observational nature allows for the identification… Read more: The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study

The effect of multidisciplinary open-label treatment in patients with persistent post-traumatic headache at two tertiary headache centers
CONCLUSION: A comprehensive multidisciplinary program did not produce clinically meaningful improvement in headache or associated symptoms, although patient satisfaction remained high. Further research is needed to improve treatment strategies.Clinical trial registration: The ClinicalTrials.gov identifier is NCT05328635.
Correlates of Persistent Post-Concussive Symptoms: Results From a Nationally Representative Cohort of Canadian Armed Forces Personnel
CONCLUSIONS: Findings identified individuals with the highest odds of experiencing PPCS. Those with PPCS, compared to those without, had a higher prevalence of co-occurring symptoms and conditions, including mental disorders, chronic pain conditions, and poor psychosocial functioning. Implications include the need for interdisciplinary care to diagnose and manage complex symptoms and comorbidities, and attention to […]
Exposure-based Interventions for Chronic Pain and Bodily Symptoms: A Special Interest Meeting Report
More than two decades have passed since exposure-based interventions were first applied to four individuals with chronic low back pain reporting pain-related fear. To reflect on the progress made since then, an international Special Interest Meeting gathered experts for two days of active dialogue and discussion focusing on the theoretical foundations of exposure-based interventions and […]
A call to arms: the absence of standardized return to play guidelines for professional rugby union players after cervical spine surgery
Cervical spine injuries in elite rugby union, while infrequent, carry a disproportionately high risk for players. The nature of collisions in rugby creates unique biomechanical stresses on the cervical spine, heightening the risk of catastrophic injury. Injuries vary across a spectrum from transient neuropraxia ('stingers') to structural injuries requiring surgical intervention. Despite the gravity of […]
Establishment and External Validation of a Nomogram for Predicting In-Hospital Mortality in Patients With Maxillary Fractures Combined With Basilar Skull Fractures: An Analysis of the Medical Information Mart for Intensive Care IV Clinical Database
CONCLUSIONS AND RELEVANCE: The study developed and validated a nomogram for early risk stratification and care planning in patients with maxillary and basilar skull fractures in emergency and critical care.

Clinical Intelligence Report

Top Conditions

Study Types

Modalities

Biomarkers (Top 20)

Outcomes (Top 20)

Effect Direction

Related Posts

Leave a Comment Cancel Reply